Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

USANA HEALTH SCIENCES INC Director's Dealing 2014

Dec 11, 2014

32704_dirs_2014-12-11_16a3c9ff-24a0-437a-83f3-0365dc2d5879.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: USANA HEALTH SCIENCES INC (USNA)
CIK: 0000896264
Period of Report: 2014-12-09

Reporting Person: WENTZ MYRON W (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2014-12-09 Common Stock M 95755 $39.18 Acquired 6539077 Indirect
2014-12-09 Common Stock S 95755 $100.2142 Disposed 6443322 Indirect
2014-12-10 Common Stock S 7000 $100.7341 Disposed 68788 Indirect

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2014-12-09 Stock Options (right to buy) $39.18 M 95755 Disposed 2015-12-05 Common Stock (95755) Direct

Footnotes

F1: Weighted average price. Price range in multiple transactions was $100.00 to $103.00, inclusive.

F2: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz and the parent of Gull Holdings, Ltd.

F3: Held of record by Gull Holdings, Ltd., a wholly owned subsidiary of Gull Global Limited and indirectly wholly owned and controlled by Dr. Myron W. Wentz.

F4: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 3, 2014.

F5: Weighted average price. Price range in multiple transactions was $99.25 to $101.95, inclusive. The reporting person undertakes to provide USANA Health Sceinces, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth in footnotes (3) and (5).